Algert Global’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
+30,520
| New | +$2.28M | 0.05% | 590 |
|
|
2024
Q3 | – | Sell |
-22,972
| Closed | -$1.9M | – | 1347 |
|
|
2024
Q2 | $1.9M | Sell |
22,972
-30,945
| -57% | -$2.56M | 0.06% | 481 |
|
|
2024
Q1 | $4.6M | Buy |
53,917
+32,390
| +150% | +$2.76M | 0.18% | 174 |
|
|
2023
Q4 | $1.84M | Sell |
21,527
-3,310
| -13% | -$283K | 0.07% | 440 |
|
|
2023
Q3 | $2.23M | Buy |
24,837
+12,690
| +104% | +$1.14M | 0.1% | 331 |
|
|
2023
Q2 | $1.03M | Sell |
12,147
-25,732
| -68% | -$2.19M | 0.05% | 650 |
|
|
2023
Q1 | $3.13M | Buy |
+37,879
| New | +$3.13M | 0.15% | 206 |
|
|
2022
Q4 | – | Sell |
-11,524
| Closed | -$853K | – | 1186 |
|
|
2022
Q3 | $853K | Sell |
11,524
-2,063
| -15% | -$153K | 0.05% | 607 |
|
|
2022
Q2 | $886K | Sell |
13,587
-910
| -6% | -$59.3K | 0.07% | 531 |
|
|
2022
Q1 | $917K | Buy |
14,497
+668
| +5% | +$42.3K | 0.06% | 561 |
|
|
2021
Q4 | $733K | Buy |
13,829
+1,700
| +14% | +$90.1K | 0.09% | 384 |
|
|
2021
Q3 | $856K | Buy |
+12,129
| New | +$856K | 0.11% | 311 |
|